We are live on ! Find out more
TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
-11.96%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$154M
AUM Growth
-$169M
Cap. Flow
-$150M
Cap. Flow %
-97.18%
Top 10 Hldgs %
83.53%
Holding
39
New
5
Increased
3
Reduced
12
Closed
18

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$2.7M
2
ANGO icon
AngioDynamics
ANGO
+$83.2K

Top Sells

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.5M
2
MDRX
Veradigm Inc. Common Stock
MDRX
+$6.49M
3
VTRS icon
Viatris
VTRS
+$5.99M
4
THC icon
Tenet Healthcare
THC
+$5.61M
5
ABT icon
Abbott
ABT
+$4.91M

Sector Composition

Rank Sector Weight
1 Healthcare 32.49%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCGO icon
26
DocGo
DCGO
$64.2M
– –
-135,000
Closed -$1.26M
DXCM icon
27
DexCom
DXCM
$29B
– –
-16,000
Closed -$1.8M
INMD icon
28
InMode
INMD
$871M
– –
-75,000
Closed -$2.8M
IRWD icon
29
Ironwood Pharmaceuticals
IRWD
$586M
– –
-225,000
Closed -$2.39M
KVUE icon
30
Kenvue
KVUE
$38B
– –
-1,000
Closed -$26.4K
RDNT icon
31
RadNet
RDNT
$4.98B
– –
-140,000
Closed -$4.57M
RIGL icon
32
Rigel Pharmaceuticals
RIGL
$723M
– –
-125,000
Closed -$1.61M
SPB icon
33
Spectrum Brands
SPB
$2.03B
– –
-10,000
Closed -$781K
TECH icon
34
Bio-Techne
TECH
$11.2B
– –
-4,000
Closed -$327K
TEVA icon
35
Teva Pharmaceuticals
TEVA
$40.4B
– –
-450,000
Closed -$4.19M
TLT icon
36
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
– –
-150,000
Closed -$15.4M
OLK
37
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
– –
-15,000
Closed -$281K
SLGC
38
CALL
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
– –
-20,000
Closed -$46.2K
SLGC
39
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
– –
-110,000
Closed -$254K
1
2

Similar funds

SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

Tamarack Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, Tamarack Advisers held 39 positions worth $154M, down 52% from $324M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Tamarack Advisers withdrew a net $150M in Q3 2023, closing 18 positions and reducing 12 holdings. Its most notable exit was BioMarin Pharmaceuticals, an estimated $6.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 40% a quarter earlier, followed by Consumer Staples.

Against the trend, Tamarack Advisers added an estimated $2.7M to Becton Dickinson.

  • Tamarack Advisers added most to Becton Dickinson in Q3 2023, an estimated $2.7M increase.
  • Tamarack Advisers's biggest Q3 2023 reduction was Veradigm Inc. Common Stock, cutting an estimated $6.49M.
  • Tamarack Advisers fully exited BioMarin Pharmaceuticals in Q3 2023, selling an estimated $6.5M.
  • Tamarack Advisers's ten largest holdings make up 84% of its $154M portfolio in Q3 2023.
  • Tamarack Advisers opened 5 new positions and closed 18 in Q3 2023.
  • Tamarack Advisers's portfolio value fell 52% quarter-over-quarter to $154M.

Based on Tamarack Advisers's 13F filing for Q3 2023, filed 16 Nov 2023.